Apricus Biosciences Inc (NASDAQ:APRI) shares are rising by 3% in Thursday’s trading on the news that Apricus has completed the sale to …
VIVUS, Inc. (NASDAQ:VVUS) investors celebrate a 14% gain in the stock this morning, after the company announced an agreement providing Metuchen Pharmaceuticals a fully-paid, …
In a research report released today, Needham analyst Alan Carr maintained a Hold rating on VIVUS, Inc.(NASDAQ:VVUS), following the company’s fourth-quarter results, posting $12.
